Overall, the present findings demonstrate that administration of the reversible KOP antagonist LY2444296 reduced physical signs of withdrawal and selectively decreased alcohol self-administration in rats with a history of alcohol dependence at 8 h abstinence. The gene discussed is OPRK1; the disease is alcohol dependence.